Remed Co.,Ltd. (KOSDAQ:302550)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,105.00
-60.00 (-1.90%)
At close: Feb 13, 2026
Market Cap95.97B -9.6%
Revenue (ttm)24.26B +3.6%
Net Income3.28B -32.6%
EPS103.55 -34.8%
Shares Out30.91M
PE Ratio29.99
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume115,645
Average Volume120,348
Open3,150.00
Previous Close3,165.00
Day's Range3,105.00 - 3,175.00
52-Week Range2,640.00 - 4,595.00
Beta0.67
RSI60.46
Earnings DateMar 18, 2026

About Remed

Remed Co.,Ltd. engages in the manufacture and supply of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as stroke, autism, dementia, Parkinson's disease, developmental disorders, and tinnitus. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells, and contraction and relaxation of muscles, as well as core muscle strengthening magnetic stimulation to enable building toned and shaped muscles. In a... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2003
Employees 92
Stock Exchange KOSDAQ
Ticker Symbol 302550
Full Company Profile

Financial Performance

In 2024, Remed's revenue was 25.55 billion, an increase of 37.86% compared to the previous year's 18.54 billion. Earnings were 7.17 billion, an increase of 799.69%.

Financial Statements